Position in BTAI
as of Dec 31, 2025
· filed Feb 12, 2026
Position Value
$204,001
New position
Shares Held
127,501
first reported quarter
Ownership
0.413%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026JANE STREET GROUP, LLC holds $181,878,118 across 41 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,464,638 | $44,114,896 | |
| 2 | LQDA |
Liquidia Corp
|
795,884 | $30,036,661 | |
| 3 | VTRS |
Viatris Inc
|
2,192,665 | $29,622,903 | |
| 4 | HLN |
Haleon plc
|
2,291,768 | $22,940,596 | |
| 5 | BCRX |
Biocryst Pharmaceuticals Inc
|
622,607 | $5,927,217 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
240,170 | $4,985,929 | |
| 7 | AQST |
Aquestive Therapeutics, Inc.
|
1,030,050 | $4,274,707 | |
| 8 | XERS |
Xeris Biopharma Holdings, Inc.
|
725,616 | $4,208,572 |
All Filings in BTAI
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $204,001 | 127,501 | Shares | Defined | 2026-02-12 | |
| No filing history on record for this holder in this stock. | ||||||